Green Growth Brands Past Earnings Performance
Past criteria checks 0/6
Green Growth Brands's earnings have been declining at an average annual rate of -222.3%, while the Pharmaceuticals industry saw earnings growing at 8.5% annually.
Key information
-222.3%
Earnings growth rate
-113.9%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | n/a |
| Return on equity | -235.2% |
| Net Margin | -242.8% |
| Last Earnings Update | 28 Dec 2019 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Green Growth Brands makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 28 Dec 19 | 47 | -113 | 81 | 0 |
| 28 Sep 19 | 28 | -92 | 67 | 0 |
| 30 Jun 19 | 16 | -64 | 49 | 0 |
Quality Earnings: GGBX.F is currently unprofitable.
Growing Profit Margin: GGBX.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if GGBX.F's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare GGBX.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GGBX.F is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-17.3%).
Return on Equity
High ROE: GGBX.F has a negative Return on Equity (-235.25%), as it is currently unprofitable.